Paul Unwin is the Industrial Chair of the Additive Manufacturing Strategy Steering Group (AM UK). AM UK is an independent, government-backed collaboration, positioned to help drive the UK’s AM strategy. The national strategy published in September 2017 provides recommendations to enable UK industry to unlock the full commercial potential of additive manufacturing and presents the output of 5 years of work undertaken by the UK AM community.
Previously, Dr Unwin was the founding CEO of the Stanmore Implants Worldwide Ltd, who are a world renowned specialist orthopaedic implant service provider. Paul was the creator and architect of a ground-breaking patient-specific implant system that integrated patient imaging, implant design, implant manufacture utilising Additive Manufacturing and placing the implants with the aid of robotics, culminating in the successful surgical placement - a world first. Paul and his team began investigating additive manufacturing for orthopaedic implants in 2006 and after following an extensive development programme built and implanted one of the first additive manufactured mega bone replacements in 2011.